Fundamental Analysis of SAFE ORTHOPAEDICS SA(EPA:ALSAF) stock

Fundamental Rating

Taking everything into account, ALSAF scores 2 out of 10 in our fundamental rating. ALSAF was compared to 53 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of ALSAF have multiple concerns. ALSAF is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

ALSAF had negative earnings in the past year.

In the past year ALSAF has reported a negative cash flow from operations.

In the past 5 years ALSAF always reported negative net income.

ALSAF had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -42.16%, ALSAF is not doing good in the industry: 90.20% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-42.16%
ROE	N/A
ROIC	N/A

ROA(3y)-48.38%

ROA(5y)-70.81%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 70.06%, ALSAF belongs to the top of the industry, outperforming 80.39% of the companies in the same industry.

ALSAF's Gross Margin has improved in the last couple of years.

The Profit Margin and Operating Margin are not available for ALSAF so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	70.06%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y37.04%

GM growth 5Y9.55%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALSAF does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for ALSAF has been increased compared to 1 year ago.

Compared to 5 years ago, ALSAF has more shares outstanding

ALSAF has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -5.50, we must say that ALSAF is in the distress zone and has some risk of bankruptcy.

ALSAF has a Altman-Z score of -5.50. This is amonst the worse of the industry: ALSAF underperforms 94.12% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-5.5

ROIC/WACCN/A

WACC3.23%

2.3 Liquidity

ALSAF has a Current Ratio of 0.74. This is a bad value and indicates that ALSAF is not financially healthy enough and could expect problems in meeting its short term obligations.

The Current ratio of ALSAF (0.74) is worse than 86.27% of its industry peers.

A Quick Ratio of 0.38 indicates that ALSAF may have some problems paying its short term obligations.

ALSAF's Quick ratio of 0.38 is on the low side compared to the rest of the industry. ALSAF is outperformed by 90.20% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.74
Quick Ratio	0.38

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 99.83% over the past year.

The Revenue has grown by 28.70% in the past year. This is a very strong growth!

The Revenue has been growing by 13.51% on average over the past years. This is quite good.

EPS 1Y (TTM)99.83%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%99.79%

Revenue 1Y (TTM)28.7%

Revenue growth 3Y7.64%

Revenue growth 5Y13.51%

Sales Q2Q%27.35%

3.2 Future

ALSAF is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.99% yearly.

Based on estimates for the next years, ALSAF will show a quite strong growth in Revenue. The Revenue will grow by 15.37% on average per year.

EPS Next Y99.97%

EPS Next 2Y41.42%

EPS Next 3Y25.99%

EPS Next 5YN/A

Revenue Next Year14.29%

Revenue Next 2Y17.26%

Revenue Next 3Y15.37%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

ALSAF reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year ALSAF is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as ALSAF's earnings are expected to grow with 25.99% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y41.42%

EPS Next 3Y25.99%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ALSAF!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

SAFE ORTHOPAEDICS SA

EPA:ALSAF (10/17/2024, 7:00:00 PM)

0.3001

+0 (+0.03%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap405.49K

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-42.16%
ROE	N/A
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	70.06%
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.35

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	0.74
Quick Ratio	0.38
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)99.83%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y99.97%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)28.7%

Revenue growth 3Y7.64%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

SAFE ORTHOPAEDICS SA (ALSAF.PA)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens